Strong Inverse Correlation between Serum Adiponectin Level and Heart Rate-Corrected QT Interval in an Apparently Healthy Population: A suggestion for a direct antiatherogenic effect of adiponectin

Diabetes Care

Volumn 27, Issue 5, 2004, Pages 1237-1238

  Komatsu, Mitsuhisa ^a   Ohfusa, Hirokazu ^b   Sato, Yoshihiko ^a   Yajima, Hiroki ^a   Yamauchi, Keishi ^a   Aizawa, Toru ^c   Hashizume, Kiyoshi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGANO RED CROSS HOSPITAL   (Japan)

^c SHINSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART DEATH; HEART RATE; HUMAN; IMMUNOREACTIVITY; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; OBESITY; PROTEIN DETERMINATION; PROTEIN FUNCTION; QT INTERVAL; QTC INTERVAL; RADIOIMMUNOASSAY; RISK FACTOR;

ADIPONECTIN; ARTERIOSCLEROSIS; FASTING; HEART RATE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; MIDDLE AGED; PROTEINS; REFERENCE VALUES;

EID: 2342537253     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.5.1237     Document Type: Article

References (7)

1. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thrombo Vasc Biol 23:85-89, 2003
2. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770, 2002
3. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T: Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278:2461-2468, 2003
4. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103:1057-1063, 2001
5. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295, 2002
6. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J: QTc interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84:1516-1523, 1991
7. Festa A, D'Agostino R, Rautaharju P, O'Leary DH, Rewers M, Mykkanen L, Haffner S M: Is QT interval a maker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 30:1566-1571, 1999